Yamil D. Mahmoud
Consejo Nacional De Investigaciones Científicas Y Técnicas, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic Onset.
Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026
Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.
Journal: Medicina
Published: June 27, 2025
FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.
Journal: International journal of cancer
Published: March 18, 2024
Association of PD-L1 expression with driver gene mutations and clinicopathological characteristics in non-small cell lung cancer: A real-world study of 10 441 patients.
Journal: Thoracic cancer
Published: December 23, 2023
A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins.
Journal: Glycobiology
Published: June 25, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2023
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina.
Journal: Ecancermedicalscience
Published: July 03, 2021
Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: January 07, 2021
Tissue-specific control of galectin-1-driven circuits during inflammatory responses.
Journal: Glycobiology
Published: December 08, 2020
Unveiling the immune infiltrate modulation in cancer and response to immunotherapy by MIXTURE-an enhanced deconvolution method.
Journal: Briefings in bioinformatics
Published: August 23, 2020
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation.
Journal: Cancer cell
Published: June 21, 2018
Last Updated: 09/26/2026